SYNOPSIS Plasma fibrinogen and plasminogen levels were measured in 122 male and 56 female healthy adult subjects and in 64 men with ischaemic heart disease. Plasma fibrinogen levels were found to rise markedly and progressively with age in both male and female healthy subjects; plasminogen showed only a slight rise with age. No sex differences were found for either fibrinogen or plasminogen. The correlation between plasminogen and fibrinogen levels was low, reaching the 5 Y.
Fletcher, and . The results are expressed in Sherry units (the release of 180 pg. tyrosine in 60 minutes). The mean difference between duplicates of 50 samples in the range 3-37 to 5-33 casein units/ml. was 0-09 casein units/ml. (standard deviation 0 09 casein units/ml.).
PLASMA FIBRINOGEN This was determined by a modification of the method of Ratnoff and Menzie (1951) . Oxalated plasma, 0-25 ml., was mixed with 4-5 ml.
0-85 % saline and 0-2 ml. thrombin (100 units/ml.).
After standing for 30 minutes the clots were filtered on squares of fibre glass and washed with saline. The clots were compressed in the fibre glass to remove the fluid trapped in the fibrin interstices. After further washing the fibrin the fibre glass was dried between cloths. The folded fibre glass squares with the enclosed fibrin was boiled with 2 ml. 0-2 N sodium hydroxide for 10 minutes. When cool, 6 ml. 12-5 % w/v sodium carbonate and 1 ml.
Folin-Ciocalteu's reagent (diluted 1:2) were added. After 15 minutes the intensity of the colour was read at 670 miu. The fibrin content of the clot was read from a standard curve prepared from purified fibrinogen (Kabi Pharmaceuticals Ltd.). All determinations were performed in duplicate.
Blood samples were obtained with the minimum of venous stasis from an ante-cubital vein. Fibrinogen estimations were performed within two hours of venepuncture and the plasminogen assays within 24 hours. It was found that storage of plasma for 48 hours at room temperature did not affect the plasminogen level. Blood was obtained between 9 and 10 a.m. from the majority of the subjects, and between 2 and 3 p.m. from the remainder.
SUBJECTS
HEALTHY suB1EcTs These comprised volunteers from a number of organizations, students, and members of the 352 medical staff. They were included if they gave no history of chest pain or other history suggestive of atherosclerotic disease, and no recent infection or other illness. In a number of the older subjects an electrocardiogram was carried out to exclude an ischaemic pattern.
ISCHAEMIC HEART DISEASE PATIENTS These were patients who had sustained a transmural myocardial infarction confirned by electrocardiography and sequential transaminase changes at least three months previously. The majority were receiving therapeutic doses of phenindione or warfarin sodium. Table I shows the fibrinogen and plasminogen levels in blood obtained at 9 a.m. and 3 p.m. in five subjects. It can be seen that there is little difference in the levels of fibrinogen or plasminogen between these times. The results obtained from subjects at 3 p.m. have therefore been pooled with those obtained at 9 a.m. Figure 1 illustrates the plasminogen levels in two subjects tested on several occasions over a period of 18 and 31 months. The plasminogen levels remained relatively constant over the period studied. Table III shows the mean fibrinogen levels in men and women in the same age groups. Again the difference between the sexes is not significant in any of the age groups, but there is a marked rise with age in both sexes. Regressions
RESULTS
Men, y = 239-8 + 2 38x -00005x2 (r = + 0-52, P < 0001) Women, y = 283-9 + 1 64x -0003x2 (r = + 037, P < 0-01) where y = fibrinogen level in mg./100 ml. and x = age in years.
The coefficient of correlation between plasminogen and fibrinogen was calculated for males and females Age Group Males separately. For males the correlation was just significant (r = + 0-20, p < 0 05), but failed to reach the 5% significance level for women (r = + 0 16, p > 0-1). The plasma fibrinogen level has been found to be unaffected by therapeutic doses of phenindione (Merskey et al., 1960; Eastham and Morgan, 1963) or by warfarin sodium (Nakamura, Kunitake, Fujita, and Reilly, 1964) . Table IV presents the mean levels of plasminogen and fibrinogen before and after three to four months of treatment with therapeutic doses of warfarin sodium in five subjects. These results confirm that oral anticoagulants do not affect fibrinogen levels and show that plasminogen levels are not altered by such therapy. Table V compares the plasminogen levels in healthy male subjects with those in male patients with ischaemic heart disease. The ischaemic heart disease patients have a significantly higher plasminogen level only in the age group 31-45 years.
Table VI compares the fibrinogen levels in the two groups. Again it is only the younger ischaemic heart disease patients who have a significantly higher fibrinogen level than healthy controls of a similar age.
DISCUSSION
There have been few studies of plasminogen levels in health. Jacobsen (1964) and Hedner and Nilsson (1965) found no significant age or sex differences in plasminogen level, but the number of subjects studied was relatively small. We have also found no sex difference in plasminogen levels, but have found a small rise with age in healthy subjects over the age range 20 to 65 years. Ischaemic heart disease patients had plasminogen levels which did not differ significantly from age-matched controls apart from the small group of patients under the age of 45 who had a significantly increased plasma plasminogen. There is no evidence, therefore, that plasminogen deficiency is important in the causation of thrombotic disease.
Studies of the changes in fibrinogen concentration with age have produced general agreement that concentrations rise with increasing age (Schulz, 1955; Pilgeram, 1961) and our results confirm this. There is disagreement, however, on sex differences in plasma fibrinogen concentration. Hume (1961) concluded that there was no increase in adult women until after the 40-65 years age group whereas there was a progressive rise in men throughout adult life. We have found that both men and women have a progressive rise in fibrinogen with age without a significant sex difference in any age group. There was no particular increase in the post-menopausal years. Several investigators have reported that fibrinogen levels are raised in patients with ischaemic heart disease (Merskey et al., 1960; Pilgeram, 1961) , but there is not complete agreement (Naimi, Goldstein, and Proger, 1963) . Katz et al. (1963) studied younger patients with ischaemic heart disease and found them to have significantly higher fibrinogen levels than age-matched controls. In the present study a significantly increased plasma fibrinogen level was found only in younger patients with ischaemic heart disease.
Although clots made from plasma with a high concentration of fibrinogen are more resistant to lysis than those made at a lower concentration there is no information to indicate whether this applies to thrombi in vivo. The role of a raised plasma fibrinogen level in the causation of thrombotic disease is therefore not known. Our results would suggest that the fibrinogen concentration in blood is of little importance in theproduction ofthrombotic complications of atheroma, but the finding of raised fibrinogen levels in young ischaemic heart disease patients leaves this possibility sub judice.
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